Pregabalin Extended Release 50228-0464
Generic: Pregabalin
Product NDC
50228-0464- Manufacturer
- Sciegen Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- September 14, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA215675
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pregabalin | 330 mg/1 |
Packaging Options(2)
500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-464-05)
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-464-30)